Skip to main navigation Skip to search Skip to main content

Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity

  • Jennifer E. Fenner
  • , Robyn Starr
  • , Ann L. Cornish
  • , Jian Guo Zhang
  • , Donald Metcalf
  • , Robert D. Schreiber
  • , Kathleen Sheehan
  • , Douglas J. Hilton
  • , Warren S. Alexander
  • , Paul J. Hertzog

Research output: Contribution to journalArticlepeer-review

Abstract

Suppressor of cytokine signaling 1 (SOCS1) is a critical regulator of cytokine signaling and immune responses. SOCS1-deficient mice develop severe inflammatory disease, but are very resistant to viral infections. Using neutralizing antibody to type I interferon (IFN-α and IFN-β) and mice deficient in interferon-γ or type I interferon receptor components (IFNAR1 or IFNAR2), we demonstrate here that SOCS1 deficiency amplified type I interferon antiviral and proinflammatory actions independently of interferon-γ. The mechanism of the suppression of type I interferon responses by SOCS1 was distinct from that of other cytokines. SOCS1 associated with and regulated IFNAR1- but not IFNAR2-specific signals, abrogating tyrosine phosphorylation of transcription factor STAT1 and reducing the duration of antiviral gene expression. Thus, SOCS1 is an important in vivo inhibitor of type I interferon signaling and contributes to balancing its beneficial antiviral versus detrimental proinflammatory effects on innate immunity.

Original languageEnglish
Pages (from-to)33-39
Number of pages7
JournalNature immunology
Volume7
Issue number1
DOIs
StatePublished - Jan 2006

Fingerprint

Dive into the research topics of 'Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity'. Together they form a unique fingerprint.

Cite this